Insider executes options and 10b5-1 sales at NBIX

The filing reports insider transactions by an individual identified as Ingrid Delaet.

Rhea-AI Filing Summary

The filing reports insider transactions by an individual identified as Ingrid Delaet. It shows an exercise of stock options resulting in 14,571 shares on 07/07/2026 (cash exercise) and prior 10b5-1 sales of 2,261 shares on 05/29/2026 for $354,321.31.

Insights

Corporate Governance Specialist

Exercise plus planned sales recorded; routine compensation and pre-arranged dispositions.

The filing lists an option exercise for 14,571 shares on 07/07/2026 that was paid in cash, and earlier 10b5-1 sales of 2,261 shares on 05/29/2026 for $354,321.31. The excerpt attaches the sales to a Rule 10b5-1 plan, indicating scheduled disposals.

Cash-flow treatment to the issuer or further disposition details are not shown in the excerpt; subsequent filings would show net holdings after these transactions.

Key Figures

Option exercise: 14,571 shares 10b5-1 sales: 2,261 shares Proceeds reported: $354,321.31

3 metrics

Option exercise 14,571 shares exercise of stock options on 07/07/2026

10b5-1 sales 2,261 shares sales on 05/29/2026

Proceeds reported $354,321.31 proceeds from 10b5-1 sales on 05/29/2026

Key Terms

10b5-1, exercise of stock options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for INGRID DELAET 6027 Edgewood"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Exercise of Stock Options | Issuer | 14571 | 07/07/2026"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What transactions are reported in the NBIX Form 144?

The filing shows an exercise of stock options for 14,571 shares on 07/07/2026 and prior 10b5-1 sales of 2,261 shares on 05/29/2026 for $354,321.31.

Who executed the 10b5-1 sales reported in the filing?

The excerpt identifies the seller as Ingrid Delaet, with 10b5-1 sales of 2,261 shares on 05/29/2026 generating $354,321.31 in proceeds as reported in the filing.

How was the 14,571-share transaction carried out?

The filing describes the 14,571-share transaction on 07/07/2026 as an exercise of stock options paid in cash, according to the transaction line in the excerpt.

Does the filing state whether proceeds go to the company or an individual?

The provided excerpt states the 10b5-1 sales proceeds amount ($354,321.31) and labels the exercise as cash, but it does not specify recipient details beyond the seller in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/07/2026 - 04:33 PM Accepted by SEC EDGAR 07/07/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965808
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEUROCRINE BIOSCIENCES, INC.
SEC File Number	000-22705
Address of Issuer	6027 Edgewood Bend Court San Diego CALIFORNIA 92130
Phone	8586177600
Name of Person for Whose Account the Securities are To Be Sold	INGRID DELAET
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14571	2536811.10	100549983	07/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2026	Exercise of Stock Options	Issuer			14571	07/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court San Diego CA 92130	Common	05/29/2026	2261	354321.31

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ingrid Delaet
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)